Self-Monitoring of Blood Glucose SMBG

In general, third-party payers for healthcare services, such as governments, public insurers, and private insurers, are motivated to provide treatments to their subscribers that have been determined to be (cost-) effective [124] in comparison to standard care. Furthermore, decision makers do also consider the impact of the respective technology on their budgets. 

---

Portable meters for measurement of blood glucose concentrations are used in three major settings (a) in acute and chronic care facilities (at the patient s bedside and in clinics or hospitals) (b) in physicians offices and (c) by patients at home, work, and school. The last, self-monitoring of blood glucose (SMBG), used by approximately 1 miUion diabetic patients, is performed in the United States at least once a day by 40% and 26% of individuals with type 1 and 2 diabetes, respectively. The worldwide market for SMBG is 2.7 billion per year, with annual growth estimated at 10% to 12%. ... 

Tunis SL (2011) Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin impact of modelling assumptions on recent Canadian findings. Appl Health Econ Health Policy 9(6) 351-365... 

SMBG Self-monitoring of blood glucose UPT Urine pregnancy test... 

Figure 5.3 Simulation of the incorporation of different amounts of error into self-monitoring blood glucose (SMBG) readings (a) — lOmg/dL, (b) — 20mg/dL, (c) —40mg/dL, and (d) —80 mg/dL. Copyright 2008 Abbott. Used with permission.

---